Editor(s):
(1) Dr. Jehad M. H. Ighbareyeh, Professor, Al-Quds Open University, Hebron Branch, Abu ktellah St., Hebron, Hebron, Palestine.
Reviewers:
(1) Flyndon Mark S. Dagalea, University of Eastern Philippines, Philippines.
(2) Uppuluri Spandana, Nirmala college of Pharmacy, Acharya Nagarjuna University, India.
(3) Shravan Kumar Paswan, Amity University, India.
(4) Samuel A. Oladosu, Obafemi Awolowo Uniersity, Nigeria.
Additional Reviewers:
(1) Kamurthy Hemalatha, Acharya & BM Reddy College of Pharmacy, India.
(2) Aditi Munmun Sengupta, University of Calcutta, CMRI Hospital, India.
(3) Ashwani K. Dhingra, Guru Gobind Singh College of Pharmacy, India.
(4) Dilip Kr. Goswami, Sri Sri College of Ayurvedic Science and Research Hospital , Sri Sri University, India.
(5) Idrissa Assumani Zabo, National Pedagogical University in Kinshasa, Congo.
(6) Jhinuk Basu Mullick, University of Florida, USA.
(7) Mohd Mustaque Ahmed, United College, India.
(8) Nagham Mahmood Aljamali, Iraq.
(9) R.Hepzi Pramila Devamani, V.V.Vanniaperumal College for Women, India.
(10) Richard Koskei, Dedan Kimathi University of Technology, Kenya.
(11) Robert Suslo, Wroclaw Medical University, Poland.
(12) S. Murugesan, National Institute of Siddha, India.
(13) Thitiphan Chimsook, Maejo University, Thailand.
(14) Utthapon Issara, Rajamangala University of Technology Thanyaburi, Thailand.
(15) Vijetha Pendyala, Chebrolu Hanumaiah Institute of Pharmaceutical Sciences, India.
Open Peer Review Policy: Click Here
Specific Comment:
Average Peer review marks at initial stage: 8.38/10
Average Peer review marks at publication stage: 9/10
Peer Review History:
Stage 1 | Original Manuscript | File 1 | NA
Stage 2 | Peer review report_1 (Flyndon Mark S. Dagalea, Philippines) | File 1 | NA
Stage 2 | Peer review report_2 (Uppuluri Spandana, India) | File 1 | NA
Stage 2 | Peer review report_3 (Shravan Kumar Paswan, India) | File 1 | File 2
Stage 2 | Peer review report_4 (Samuel A. Oladosu, Nigeria) | File 1 | NA
Stage 2 | Revised_MS_v1_and_Feedback_v1 | File 1 | File 2
Stage 3 | Comment_Editor_1_v1 | File 1 | NA